Qualigen shares surge 11.72% after-hours after rebranding to AIxCrypto and pivoting to AI/Web3 with Faraday Future as majority shareholder.

Qualigen Therapeutics surged 11.72% in after-hours trading following its announcement to rebrand as AIxCrypto Holdings, Inc. and pivot from biotechnology to a decentralized artificial intelligence (DeAI) and Web3 platform. The company formalized the transition by filing for a name change and ticker symbol shift to AIXC, effective November 20, 2025, alongside Faraday Future Intelligent Electric Inc. securing a 55% direct equity stake. Shareholders approved the strategic overhaul, including a private placement of shares and governance changes aligning with the new focus. The rebranding, coupled with Faraday Future’s majority ownership and the unveiling of a three-year development roadmap, signaled a significant corporate transformation into the AI x Web3 sector, driving investor optimism in after-hours trading.